Nonalcoholic fatty liver disease, association with cardiovascular disease snd treatment. (1). Nonalcoholic fatty liver disease and its association with cardiovascular disease
Por:
Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J and Pedro-Botet J
Publicada:
1 may 2017
Ahead of Print:
27 sep 2016
Resumen:
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world and, from the point of view of the liver, in its gradual progression from steatosis to steatohepatitis, cirrhosis, and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with acceleration of arteriosclerosis and events related to it, being the main cause of its morbidity and mortality. This review, updated to January 2016, consists of two parts, with the first part analysing the association of NAFLD with cardiovascular disease. (C) 2016 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.
Filiaciones:
Brea Á:
Unidad de Lípidos, Servicio de Medicina Interna, Hospital San Pedro, Logroño, España.
Pintó X:
Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge, Idibell. CiberObn, L'Hospitalet de Llobregat, Barcelona, España
Ascaso JF:
Servicio de Endocrinología, Hospital Clínico , Valencia, España
Blasco M:
Atención Primaria, Área Sanitaria de Delicias, Zaragoza, España
Díaz Á:
Centro de Salud de Bembibre, Bembibre, León, España
González-Santos P:
Departamento de Medicina, Universidad de Málaga
:
Servicio de Endocrinología, Hospital Universitario Dr. Peset, Universitat de València , Valencia, España
Mantilla T:
Atención Primaria, Centro de Salud de Prosperidad, Madrid, España
Millán J:
Unidad de Lípidos, Servicio de Medicina Interna, Hospital General Universitario Gregorio Marañón, Universidad Complutense , Madrid, España
Pedro-Botet J:
Unidad de Lípidos y Riesgo Vascular, Servicio de Endocrinología y Nutrición, Hospital del Mar, Universitat Autònoma de Barcelona , Barcelona, España
Green Accepted
|